Sarah Kim is currently a 3rd year medical student at Drexel University College of Medicine. After receiving her B.S. in Molecular, Cellular & Developmental Biology from the University of Washington, her interests in both medicine and science led her to do a year of research in the Clowes Lab at the University of Washington School of Medicine. Here, she studied the processes involved in intimal hyperplasia responsible for graft rejection, and more specifically, the Vasodilator-stimulated phosphoprotein (VASP) and its effects on actin cytoskeletal remodeling and smooth muscle cell migration and invasion. Her work led to a Journal of Cellular Physiology publication, of which she is first co-author.
Last Summer, between her first and second year of medical school, she was awarded the William J. von Liebig Vascular Surgery Research Fellowship. She spent the Summer at Harvard Medical School, investigating potential anticoagulants in the Furie Lab, in collaboration with the Flaumenhaft Lab at Beth Israel Deaconess Medical Center. During the upcoming year, she will be continuing her research on these novel anticoagulants in the Furie Lab, with generous support from the AMA Seed Grant and the Sarnoff Cardiovascular Research Fellowship.